Targeting regulator of mitochondrial cell death delivers anticancer activity
A novel anticancer molecule created by researchers at The Wistar Institute showed therapeutic activity in preclinical models of various cancer […]
» Read moreHome »
Active mutations of a certain signaling receptor protein called KIT tyrosine kinase are found in several cancers, such as acute […] Cancer is a multidisciplinary disease, with different mutations leading to different prognoses and treatment necessities. Among the most important mutation […] So concluded researchers from the Wake Forest School of Medicine in Winston-Salem, NC, after having compared the effects of Western […] Patients suffering sudden liver failure could in the future benefit from a new treatment that could reduce the need for […]
Discovery of novel cancer signaling mechanism and design of new anticancer compound
Anticancer drug candidate inhibits lethal aggregation of mutant tumor suppressor protein
Mediterranean diet promotes anticancer bacteria in the breast
Anticancer drug offers potential alternative to transplant for patients with liver failure
